| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Annals of Thoracic Surgery, Vol 57, 1416-1422, Copyright © 1994 by The Society of Thoracic Surgeons
OH Frazier, MP Macris, TJ Myers, JM Duncan, B Radovancevic, SM Parnis and DA Cooley
In the past, left ventricular assist device (LVAD) support was frequently
plagued by complications; thus, bridge to transplantation times were kept
short. Increasing evidence suggests that extended bridging provides greater
benefit due to improved end-organ perfusion and, thus, generally improved
physical condition. To assess whether extended bridging translates into
improved long-term survival after transplantation, we reviewed our
experience with the HeartMate 1000 IP LVAD (Thermo Cardiosystems, Inc,
Woburn, MA). Since January 1988, 19 patients (mean age, 45 +/- 9 years)
have undergone extended bridging (mean time, 106 +/- 57 days). Their mean
weight was 82 +/- 16 kg, and their mean body surface area was 2.0 +/- 0.2
m2. We define "extended" as the length of support necessary for systemic
organ recovery after prolonged heart failure. During support, average pump
flow indices ranged from 2.3 to 3.3 L.min-1.m-2, and all patients underwent
physical rehabilitation. Between the time of LVAD implantation and
explantation, the mean serum creatinine value decreased from 1.63 +/- 0.6
to 1.25 +/- 0.6 mg/dL (p = not significant), and the mean serum total
bilirubin value decreased from 2.8 +/- 2.0 to 0.63 +/- 0.11 mg/dL (p <
0.05). All but 1 patient improved from New York Heart Association class IV
to class I. Device-related complications were minimal. Twelve control
patients ("de facto randomized") who did not receive the LVAD also were
evaluated: actuarial survival at 1 year was 0% (p < 0.05); 3 (25%)
underwent transplantation and died within 2 months; 9 (75%) died before
transplantation.(ABSTRACT TRUNCATED AT 250 WORDS)
ARTICLES
Improved survival after extended bridge to cardiac transplantation
Department of Cardiovascular Research, Texas Heart Institute/St. Luke's Episcopal Hospital, Houston.
This article has been cited by other articles:
|
|
 |
|
  E. A. Genovese, M. A. Dew, J. J. Teuteberg, M. A. Simon, J. Kay, M. P. Siegenthaler, J. K. Bhama, C. A. Bermudez, K. L. Lockard, S. Winowich, et al. Incidence and patterns of adverse event onset during the first 60 days after ventricular assist device implantation. Ann. Thorac. Surg., October 1, 2009; 88(4): 1162 - 1170. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Clegg, D. A. Scott, E. Loveman, J. L. Colquitt, P. Royle, and J. Bryant Clinical and cost-effectiveness of left ventricular assist devices as a bridge to heart transplantation for people with end-stage heart failure: a systematic review and economic evaluation Eur. Heart J., December 2, 2006; 27(24): 2929 - 2938. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Alegria, J. Herrmann, D. R. Holmes Jr, A. Lerman, and C. S. Rihal Myocardial bridging Eur. Heart J., June 2, 2005; 26(12): 1159 - 1168. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Gammie, L. B. Edwards, B. P. Griffith, R. N. Pierson III, and L. Tsao Optimal timing of cardiac transplantation after ventricular assist device implantation J. Thorac. Cardiovasc. Surg., June 1, 2004; 127(6): 1789 - 1799. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. P. Uray, J. H. Connelly, O.H. Frazier, H. Taegtmeyer, and P. J.A. Davies Mechanical unloading increases caveolin expression in the failing human heart Cardiovasc Res, July 1, 2003; 59(1): 57 - 66. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. W. Miller Patient selection for the use of ventricular assist devices as a bridge to transplantation Ann. Thorac. Surg., June 1, 2003; 75(90060): S66 - 71. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. D. Aaronson, M. J. Eppinger, D. B. Dyke, S. Wright, and F. D. Pagani Left ventricular assist device therapy improves utilization of donor hearts J. Am. Coll. Cardiol., April 17, 2002; 39(8): 1247 - 1254. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Razeghi, M. Mukhopadhyay, T. J. Myers, J. N. Williams, C. S. Moravec, O. H. Frazier, and H. Taegtmeyer Myocardial tumor necrosis factor-{alpha} expression does not correlate with clinical indices of heart failure in patients on left ventricular assist device support Ann. Thorac. Surg., December 1, 2001; 72(6): 2044 - 2050. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. W. Bowen, A. F. Carboni, M. L. O'Hara, A. Pochettino, B. R. Rosengard, R. J. Morris, R. C. Gorman, J. H. Gorman III, and M. A. Acker Application of ""double bridge mechanical"" resuscitation for profound cardiogenic shock leading to cardiac transplantation Ann. Thorac. Surg., July 1, 2001; 72(1): 86 - 90. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. D. Pagani, K. D. Aaronson, F. Swaniker, and R. H. Bartlett The use of extracorporeal life support in adult patients with primary cardiac failure as a bridge to implantable left ventricular assist device Ann. Thorac. Surg., March 1, 2001; 71 (2007): S77 - S81. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O.H. Frazier, T. J. Myers, R. K. Jarvik, S. Westaby, D. W. Pigott, I. D. Gregoric, T. Khan, D. W. Tamez, J. L. Conger, and M. P. Macris Research and development of an implantable, axial-flow left ventricular assist device: the Jarvik 2000 Heart Ann. Thorac. Surg., March 1, 2001; 71 (2007): S125 - S132. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. D. Pagani, K. D. Aaronson, D. B. Dyke, S. Wright, F. Swaniker, and R. H. Bartlett Assessment of an extracorporeal life support to LVAD bridge to heart transplant strategy Ann. Thorac. Surg., December 1, 2000; 70(6): 1977 - 1985. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Humphrey and R. Arena Surgical Innovations for Chronic Heart Failure in the Context of Cardiopulmonary Rehabilitation Physical Therapy, January 1, 2000; 80(1): 61 - 69. [Full Text] [PDF]
|
|
|
|
 |
|
 F. D. Pagani, W. Lynch, F. Swaniker, D. B. Dyke, R. Bartlett, T. Koelling, M. Moscucci, G. M. Deeb, S. Bolling, H. Monaghan, et al. Extracorporeal Life Support to Left Ventricular Assist Device Bridge to Heart Transplant : A Strategy to Optimize Survival and Resource Utilization Circulation, November 9, 1999; 100 (2009): II-206 - II-210. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. B. Spanier, J. M. Chen, M. C. Oz, D. M. Stern, E. A. Rose, and A. M. Schmidt TIME-DEPENDENT CELLULAR POPULATION OF TEXTURED-SURFACE LEFT VENTRICULAR ASSIST DEVICES CONTRIBUTES TO THE DEVELOPMENT OF A BIPHASIC SYSTEMIC PROCOAGULANT RESPONSE J. Thorac. Cardiovasc. Surg., September 1, 1999; 118(3): 404 - 413. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Hunt and O.H. Frazier Mechanical Circulatory Support and Cardiac Transplantation Circulation, May 26, 1998; 97(20): 2079 - 2090. [Full Text] [PDF]
|
|
|
|
|
|
S. Westaby, T. Katsumata, R. Evans, D. Pigott, D. P. Taggart, and R. K. Jarvik THE JARVIK 2000 OXFORD SYSTEM: INCREASING THE SCOPE OF MECHANICAL CIRCULATORY SUPPORT J. Thorac. Cardiovasc. Surg., September 1, 1997; 114(3): 467 - 474. [Abstract] [Full Text]
|
|
|
|
 |
|
 O.H. Frazier The development, evolution, and clinical utilization of artificial heart technology Eur. J. Cardiothorac. Surg., April 1, 1997; 11(suppl): S29 - S31. [Abstract] [PDF]
|
|
|
|
|
|
M. Herrmann, M. Weyand, B. Greshake, C. von Eiff, R. A. Proctor, H. H. Scheld, and G. Peters Left Ventricular Assist Device Infection Is Associated With Increased Mortality but Is Not a Contraindication to Transplantation Circulation, February 18, 1997; 95(4): 814 - 817. [Abstract] [Full Text]
|
|
|
|
|
|
M. G. Massad, P. M. McCarthy, N. G. Smedira, D. J. Cook, N. B. Ratliff, M. Goormastic, R. L. Vargo, J. Navia, J. B. Young, and R. W. Stewart DOES SUCCESSFUL BRIDGING WITH THE IMPLANTABLE LEFT VENTRICULAR ASSIST DEVICE AFFECT CARDIAC TRANSPLANTATION OUTCOME? J. Thorac. Cardiovasc. Surg., November 1, 1996; 112(5): 1275 - 1283. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
